Earnings Recovery, Easing FII Sales Expected to Aid Indian Equities

STOCK-INVESTMENT-IDEAS
Whalesbook Logo
AuthorAarav Shah|Published at:
Earnings Recovery, Easing FII Sales Expected to Aid Indian Equities
Overview

Valentis Advisors' Jyotivardhan Jaipuria predicts a better year for Indian equities driven by an earnings recovery and a potential slowdown in foreign institutional investor selling. He anticipates double-digit earnings growth and favors metals over the medium term, while expressing caution on IT stocks due to structural AI challenges. Chemicals and pharmaceuticals are seen as selective opportunities.

Market Outlook Shifts

Jyotivardhan Jaipuria, Founder and Managing Director of Valentis Advisors, signals a potential turnaround for Indian equities. He notes that while tariff-linked stocks face headwinds amid fading trade deal hopes, the broader market may find footing from improving corporate earnings and a deceleration in foreign capital outflows. Jaipuria expects this year to outperform last year for the stock market.

Earnings Revival

A key driver for optimism is the anticipated earnings recovery. After several quarters of sluggish single-digit growth, Jaipuria foresees the potential for double-digit earnings expansion across companies in the coming quarters. This projected earnings momentum is seen as a crucial support for stock valuations.

Foreign Investor Flows

Foreign institutional investors (FIIs) are also expected to play a more supportive role. Jaipuria suggests that FII selling may lessen as the year progresses. India's underperformance relative to the MSCI Emerging Markets Index last year, coupled with valuations returning to long-term averages, could encourage FIIs to re-engage, potentially turning them into buyers later in the year.

Sectoral Bets

Within specific sectors, metals are highlighted for their potential over the next 12 to 18 months. Despite inherent volatility, recent safeguard duties on hot-rolled coils are seen as a protective measure for domestic producers, suggesting this is an area where investors can profit. Protectionist policies could bolster the sector.

Technology Caution

Conversely, Jaipuria advises caution on information technology stocks, including major players like Tata Consultancy Services (TCS) and Infosys. He does not foresee a strong rebound, citing persistent structural challenges linked to artificial intelligence. These issues could suppress growth for several years, leading Valentis Advisors to maintain an underweight stance on the IT sector, viewing any buying opportunities as tactical rather than long-term investments.

Selective Opportunities

The chemicals and pharmaceuticals sectors present selective investment avenues. While the broader chemical industry grapples with competition from China, stock-specific catalysts like new capacity additions or export advantages could drive performance. Pharmaceutical stocks, which have experienced a prolonged period of underperformance, may now offer value as market pessimism appears to be fully priced in.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.